Cargando…
Nanoparticles laden in situ gel for sustained ocular drug delivery
Proper availability of drug on to corneal surface is a challenging task. However, due to ocular physiological barriers, conventional eye drops display poor ocular bioavailability of drugs (< 1%). To improve precorneal residence time and ocular penetration, earlier our group developed and evaluate...
Autores principales: | Gupta, Himanshu, Aqil, Mohammed, Khar, Roop K., Ali, Asgar, Bhatnagar, Aseem, Mittal, Gaurav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697196/ https://www.ncbi.nlm.nih.gov/pubmed/23833523 http://dx.doi.org/10.4103/0975-7406.111824 |
Ejemplares similares
-
An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention
por: Gupta, Himanshu, et al.
Publicado: (2015) -
Physiologically active hydrogel (in situ gel) of sparfloxacin and its evaluation for ocular retention using gamma scintigraphy
por: Gupta, Himanshu, et al.
Publicado: (2015) -
Recent advance technique for ocular drug delivery by Gupta et al.: Nanoparticle laden in situ gel
por: Gupta, Parul, et al.
Publicado: (2013) -
A stimulus-responsive, in situ-forming, nanoparticle-laden hydrogel for ocular drug delivery
por: Kabiri, Maryam, et al.
Publicado: (2018) -
Nanoparticles laden in situ gelling system for ocular drug targeting
por: Kumar, Divya, et al.
Publicado: (2013)